We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$489B
AUM Growth
+$8.01B
Cap. Flow
-$30B
Cap. Flow %
-6.13%
Top 10 Hldgs %
29.25%
Holding
15,615
New
1,894
Increased
5,212
Reduced
6,339
Closed
1,910

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.71B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$613M
3
AAPL icon
Apple
AAPL
+$478M
4
MA icon
Mastercard
MA
+$450M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$424M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Financials 2.35%
3 Healthcare 2.22%
4 Consumer Discretionary 2.21%
5 Communication Services 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOXD.WS
13451
DELISTED
Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share
BOXD.WS
$22K ﹤0.01%
+18,753
New +$17K
NVSAW
13452
DELISTED
New Vista Acquisition Corp. Warrant
NVSAW
$22K ﹤0.01%
29,793
-182,638
-86% -$147K
LGV.WS
13453
DELISTED
Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
LGV.WS
$22K ﹤0.01%
26,466
-98,618
-79% -$112K
USWS
13454
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$22K ﹤0.01%
3,258
-2,503
-43% -$30.7K
ETTX
13455
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$22K ﹤0.01%
+10,197
New +$27.6K
AFI
13456
CALL
DELISTED
Armstrong Flooring, Inc.
AFI
$22K ﹤0.01%
11,000
-7,300
-40% -$17.6K
BWEN icon
13457
CALL
Broadwind
BWEN
$127M
$21K ﹤0.01%
11,000
-27,400
-71% -$72.1K
LSTA icon
13458
PUT
Lisata Therapeutics
LSTA
$9.82M
$21K ﹤0.01%
1,627
-3,266
-67% -$50.4K
MREO
13459
PUT
Mereo BioPharma
MREO
$50.9M
$21K ﹤0.01%
13,200
-8,900
-40% -$17.8K
PHIO icon
13460
PUT
Phio Pharmaceuticals
PHIO
$12.7M
$21K ﹤0.01%
194
+17
+10% +$2.7K
MTCR
13461
CALL
DELISTED
Metacrine, Inc. Common Stock
MTCR
$21K ﹤0.01%
+31,300
New +$55.8K
ZVO
13462
PUT
DELISTED
Zovio Inc. Common Stock
ZVO
$21K ﹤0.01%
16,700
-24,600
-60% -$43.1K
TYME
13463
CALL
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$21K ﹤0.01%
34,400
+2,600
+8% +$2.23K
CPTAG
13464
DELISTED
Capitala Finance Corp. 5.75% Convertible Notes Due 2022
CPTAG
0
EVFM
13465
PUT
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$21K ﹤0.01%
3,767
+534
+17% +$4.54K
GORO icon
13466
CALL
Goldgroup Mining Inc.
GORO
$207M
$20K ﹤0.01%
12,600
-57,200
-82% -$104K
SLDB icon
13467
PUT
Solid Biosciences
SLDB
$986M
$20K ﹤0.01%
767
-3,140
-80% -$96K
SOGP
13468
PUT
Sound Group
SOGP
$47.1M
$20K ﹤0.01%
1,100
-1,510
-58% -$38.6K
GRDX
13469
GridAI Technologies Corp
GRDX
$29.5M
$20K ﹤0.01%
+1
New +$27.3K
GMBTW
13470
DELISTED
Pivotal Holdings Corp Warrant
GMBTW
$20K ﹤0.01%
31,318
JG
13471
PUT
Aurora Mobile
JG
$34.2M
$19K ﹤0.01%
910
-845
-48% -$23.4K
OPTN
13472
PUT
DELISTED
OptiNose
OPTN
$19K ﹤0.01%
+793
New +$26.5K
LFWD icon
13473
CALL
ReWalk Robotics
LFWD
$21M
$19K ﹤0.01%
181
-111
-38% -$12.7K
SPAQ.WS
13474
DELISTED
Spartan Acquisition Corp. III Warrants, exercisable for one share of Class A Common Stock
SPAQ.WS
$19K ﹤0.01%
12,960
-171,177
-93% -$224K
ONCS
13475
CALL
DELISTED
OncoSec Medical Incorporated
ONCS
$19K ﹤0.01%
+882
New +$29.8K

Similar funds

Ken Griffin's Q4 2021 Portfolio in Review

As of Q4 2021, Ken Griffin held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin withdrew a net $30B in Q4 2021, closing 1,910 positions and reducing 6,339 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ken Griffin opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.

  • Ken Griffin's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
  • Ken Griffin added most to Amazon in Q4 2021, an estimated $802M increase.
  • Ken Griffin's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
  • Ken Griffin fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
  • Ken Griffin's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
  • Ken Griffin opened 1,894 new positions and closed 1,910 in Q4 2021.
  • Ken Griffin's portfolio value rose 1.7% quarter-over-quarter to $489B.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.